We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Horse Guards Gin (HGG) aims to revive heritage spirit brands and re-introduce them to modern consumers. The company owns eight heritage trademarks including its latest brands 'Pink Gin' and 'Wing Walker Rum.' HGG intends to become a contender in the Gin and Rum markets that are forecast to grow to $17.36 billion and $21.5 billion by 2025. The company aims to launch two new premium spirits in 2021 and is in early talks around licensing to spirits businesses, including 'Ready To Drink' cocktails. HGG sold 9,000 bottles in 2020 and onboarded distributors who have access to more than 500 outlets. The company is in discussions to sign up distributor agents in Canada, South Africa, and the Middle East. The company's celebrity ambassadors include cricketing legend, Phil Tufnell. It will use the investment to accelerate new brand launches, grow its sales/marketing team, and build strategic alliances to extend brand reach.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £346,340
The Mighty Society produces a tasty, smooth and rich non-dairy substitute to milk which is made from yellow split-peas. The company is in partnership with the UK's biggest dairy substitute manufacturers, and it has sold over 66,000 units. The pea milk has been launched in 2,000 different stocking points across the UK including Sainsbury's, Marks & Spencers, Whole Foods Market and other retailers. The Mighty Society will use the funds for production, R&D, sales and marketing.
days to go: Expired investment: £443,389
Appetise is an online market place that connects consumers with local takeaway restaurants.  Consumers order food on their smart phones to be delivered by the restaurants to their homes.   They currently have 60,000 registered customers and 370 restaurants partnered in the UK and are looking to expand town by town and become a key player in this market.
days to go: Expired investment: £129,800
Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £752,246
Easy-Fit Bedding has created a cutting-edge and innovative bedding product that can open from all four sides allowing easy access when fitting one's duvet inside the duvet cover. The company set to transform bed making, globally. It is sold online in the UK and, it is also available in the USA, Asia and Europe. Easy-Fit Duvet Covers have a unique design with registered rights in Europe and a US patent. The company has won Best Fitted-Bedding Retailer 2018 by CV Magazine. With the proceeds, the company will schedule to appear on a long-term nationwide TV Campaign, aired on popular TV channels, ensuring continued development and growth in sales.
days to go: Expired investment: £21,590
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph